Supply & Demand Chain Executive Names Three RXO Leaders as Recipients of 2025 Women in Supply Chain Award
RXO(NYSE:RXO) CHARLOTTE, N.C.--(BUSINESS WIRE)---- $RXO #nyse--RXO (NYSE: RXO), a leading provider of asset-light transportation solutions, announced today that Heidi Ratti, Erica Knisely and Jayme Clarke were recognized as winners of this year’s Women in Supply Chain Award by Supply & Demand Chain Executive and Food Logistics. This award recognizes top female supply chain professionals whose accomplishments, mentorship and examples set a foundation for women in all levels of a company’s supply chain. RXO leaders have
RXO Releases New Insights on Industry-Specific KPIs Within Logistics
RXO(NYSE:RXO) CHARLOTTE, N.C.--(BUSINESS WIRE)---- $RXO #nyse--RXO (NYSE: RXO), a leading provider of asset-light transportation solutions, released new, data-backed insights that compare how hundreds of supply chain experts across different industries track and leverage their transportation data as key performance indicators (KPIs). In this new report, Logistics KPI Benchmarks, By Industry, businesses can now access an overview of top logistics KPI trends by industry vertical, as well as deep-dive KPI profiles of automoti
RXO Announces Participation at Upcoming Investor Conferences
RXOCHARLOTTE, N.C.--(BUSINESS WIRE)---- $RXO #nyse--RXO (NYSE: RXO) today announced that Chairman and CEO Drew Wilkerson and Chief Strategy Officer Jared Weisfeld will participate in the following investor conferences: Event: Jefferies Industrials Conference in New York City Presentation: Thursday, Sept. 4, 8:10 a.m. EDT Event: Morgan Stanley 13th Annual Laguna Conference in Laguna Beach, Calif. Presentation: Wednesday, Sept. 10, 1:45 p.m. EDT Live webcasts and replays of the presentations will be available at h
RXO’s Latest Curve Forecast Shows Measured Truckload Market Recovery
RXOCHARLOTTE, N.C.--(BUSINESS WIRE)---- $RXO #nyse--RXO (NYSE: RXO), a leading provider of asset-light transportation solutions, has released the latest update to its proprietary Curve truckload market forecast, which recaps Q2 2025 performance, covers macroeconomic indicators and trends driving the truckload market, and provides a Q3 2025 freight market forecast. “Freight market conditions remained soft in the second quarter. However, with continued carrier exits, the market is responding to seasonality and is
RXO Announces Second-Quarter Results
RXOCHARLOTTE, N.C.--(BUSINESS WIRE)---- $RXO #nyse--RXO (NYSE: RXO) today reported its second-quarter financial results. RXO Chairman and CEO Drew Wilkerson said, “RXO executed well in the second quarter despite the prolonged soft freight market. Our Brokerage business outperformed the market, growing volume by 1% year-over-year driven by 45% growth in less-than-truckload volume. We’re seeing early benefits from our newly combined carrier and coverage operations, and we delivered Brokerage gross margin of 14.4%
Citigroup Maintains Neutral on RXO, Raises Price Target to $18
RXOB of A Securities Maintains Neutral on RXO, Raises Price Target to $18
RXOUBS Maintains Neutral on RXO, Lowers Price Target to $14
RXOGoldman Sachs Maintains Neutral on RXO, Lowers Price Target to $18
RXOStifel Maintains Hold on RXO, Lowers Price Target to $14
RXOWells Fargo Maintains Equal-Weight on RXO, Lowers Price Target to $15
RXORXO Q1 Adj. EPS $(0.03) Misses $(0.02) Estimate, Sales $1.43B Miss $1.49B Estimate
RXOTruist Securities Maintains Buy on RXO, Lowers Price Target to $19
RXOJefferies Maintains Buy on RXO, Lowers Price Target to $20
RXOGoldman Sachs Maintains Neutral on RXO, Lowers Price Target to $21
RXOOppenheimer Downgrades RXO to Perform
RXOBarclays Maintains Overweight on RXO, Lowers Price Target to $22
RXOWells Fargo Maintains Equal-Weight on RXO, Lowers Price Target to $20
RXOSusquehanna Maintains Negative on RXO, Lowers Price Target to $13
RXOTruist Securities Initiates Coverage On RXO with Buy Rating, Announces Price Target of $24
RXOBenchmark Reiterates Hold on RXOto Hold
RXOJefferies Maintains Buy on RXO, Lowers Price Target to $30
RXOGoldman Sachs Reinstates Neutral on RXO, Announces $29 Price Target
RXO